Pro Medicus (ASX:PME) FCF Margin % : 34.41% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pro Medicus's Free Cash Flow for the six months ended in Dec. 2023 was A$25.5 Mil. Pro Medicus's Revenue for the six months ended in Dec. 2023 was A$74.1 Mil. Therefore, Pro Medicus's FCF Margin % for the quarter that ended in Dec. 2023 was 34.41%.

As of today, Pro Medicus's current FCF Yield % is 0.54%.

The historical rank and industry rank for Pro Medicus's FCF Margin % or its related term are showing as below:

ASX:PME' s FCF Margin % Range Over the Past 10 Years
Min: -7.92 Med: 30.84 Max: 56.27
Current: 45.67

During the past 13 years, the highest FCF Margin % of Pro Medicus was 56.27%. The lowest was -7.92%. And the median was 30.84%.

ASX:PME's FCF Margin % is ranked better than
98.04% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 1.44 vs ASX:PME: 45.67

Pro Medicus FCF Margin % Historical Data

The historical data trend for Pro Medicus's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus FCF Margin % Chart

Pro Medicus Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

34.17

41.47

45.91

56.27

44.95

Pro Medicus Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															51.18	60.84	29.40	57.94	34.41

Competitive Comparison of Pro Medicus's FCF Margin %

For the Health Information Services subindustry, Pro Medicus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro Medicus's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pro Medicus's FCF Margin % falls into.

Pro Medicus FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pro Medicus's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	56.089	/	124.787
	=	44.95 %

Pro Medicus's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	25.489	/	74.074
	=	34.41 %

Pro Medicus FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pro Medicus's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (ASX:PME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PMCUF:USA PMC:Germany

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.